Potassium Chloride Tablet, Extended Release
Product Images NDC 70771-1600

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Potassium Chloride (NDC 70771-1600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Kcl Tab 10meq (614aa55a 544f 48a8 88a4 B60b00d36448 01)

Potassium Chloride Extended-release Tablets, USP is a medicine that comes in a container of 100 tablets that should be kept tightly closed and dispensed in a light-resistant container. Each tablet offers 750mg potassium chloride USP which is equal to 10 mEq of potassium. It is essential to keep the medicine at room temperature (20° to 25°C). The package insert contains complete prescription information and the preparation test by USP is pending. This medication is for Rx only and is manufactured by Cadia Healthcare Ltd in Matoda, Ahmedabad, India.*

FDA Label Image

Kcl 20meq (614aa55a 544f 48a8 88a4 B60b00d36448 02)

Potassium Chloride Extended-release Tablets, USP are a medication that contains 1500 mg of potassium chloride in each extended-release tablet (equivalent to 20 mEq of potassium). The usual dosage should be followed as indicated in the package insert. The tablets need to be stored in a tightly closed, light-resistant container at a temperature between 20 to 25°C. The drug should be kept out of the reach of children. The USP assay preparation is pending. The medication is manufactured by Cadia Healthcare L. in Matoda, Ahmedabad, India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.